Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The high-mobility group nucleosomal binding domain 2 pseudogene (ENSG00000255519) is a non-coding genomic sequence that shares significant sequence similarity with the functional HMGN2 gene. Unlike the functional gene, this pseudogene does not produce a functional protein product due to accumulated mutations or the absence of essential regulatory elements. Such pseudogenes are classified based on the mechanism of their generation (e.g., processed or unprocessed) and generally do not serve as drug targets. While some pseudogenes may play regulatory roles, such as modulating the expression of their parental genes or acting as sources of non-coding RNA, the specific functional relevance of this particular pseudogene remains unestablished.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on High mobility group nucleosomal binding domain 2 pseudogene (HMGN2P).